#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13850	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2350	725.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1611	1611	C	903	C,T,A	900,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23996	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	744.4	0	.	n	.	0	T695C	SNP	695	695	T	1272	1272	C	867	C,A,T,G	861,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23996	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	744.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1914	1914	A	973	A,C,T	968,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23996	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	744.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2548	2548	C	861	C,T	860,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23996	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	744.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2622	2622	A	747	A	747	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23996	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	744.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3174	3174	C	858	C,G	857,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1960	folP	855	855	100.0	folP.l6.c17.ctg.1	1880	129.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1110	1112	AGC	209;207;207	A,C,G;G;C,A	207,1,1;207;206,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3740	147.1	1	SNP	p	S91F	1	.	.	271	273	TTC	765	767	TTC	177;179;177	T;T;C	177;179;177	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3740	147.1	1	SNP	p	D95G	1	.	.	283	285	GGC	777	779	GGC	181;182;177	G;G;C	181;182;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3740	147.1	1	SNP	p	G95N	0	.	.	283	285	GGC	777	779	GGC	181;182;177	G;G;C	181;182;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1642	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1820	112.6	1	SNP	p	G45D	0	.	.	133	135	GGC	737	739	GGC	189;191;194	G;G;C,G	189;191;193,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	972	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1282	94.4	0	.	n	.	0	A197.	DEL	197	197	A	728	728	A	203	A,T,C	201,1,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4592	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3368	170.1	1	SNP	p	D86N	0	.	.	256	258	GAC	832	834	GAC	195;196;198	G;A,G,C;C,T	194;193,1,1;196,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4592	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3368	170.1	1	SNP	p	R87I	0	.	.	259	261	CGT	835	837	CGT	198;198;199	C;G;T	197;197;199	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4592	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3368	170.1	1	SNP	p	S87R	1	.	.	259	261	CGT	835	837	CGT	198;198;199	C;G;T	197;197;199	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4592	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3368	170.1	1	SNP	p	R87W	0	.	.	259	261	CGT	835	837	CGT	198;198;199	C;G;T	197;197;199	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4592	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3368	170.1	1	SNP	p	S88P	0	.	.	262	264	TCC	838	840	TCC	197;197;196	T;C;C	196;196;196	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3786	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2962	159.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1681	1683	GGC	216;216;214	G,C;G;C,T	215,1;216;213,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1350	1352	GCA	210;213;212	G;C,T;A,G	210;212,1;211,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1353	1355	ATC	212;210;208	A;T;C	212;210;208	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1365	1367	GTG	211;211;210	G;T,G;G	211;210,1;210	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1365	1367	GTG	211;211;210	G;T,G;G	211;210,1;210	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1869	1871	ACC	217;216;217	A,C;C,T;C	216,1;215,1;217	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1923	1925	GCG	219;218;214	G;C,G;G	219;217,1;214	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1923	1925	GCG	219;218;214	G;C,G;G	219;217,1;214	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2046	2048	AGC	203;204;204	A;G;C	203;204;204	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2055	2057	GGC	205;204;202	G;G;C	205;204;202	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3694	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2652	173.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2073	2075	CCG	202;205;204	C,G;C;G,A	198,4;205;203,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5148	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3381	189.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1778	1780	CCG	204;206;202	C;C;G,A	204;206;201,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2038	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2198	115.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	771	771	C	156	C,T	155,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	30;31;32	T;T;A	30;31;32	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	62;62;62	C;A;T	62;62;62	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	62;62;62	A;G;T	62;62;62	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	63;63;63	T;A;C	63;63;63	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	1;1;2	A;G;C	1;1;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	226	90.71	porB1a.l15.c17.ctg.4	367	30.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2672	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1915	173.4	0	.	p	.	0	R143G	NONSYN	427	429	AGA	872	874	GGA	230;229;227	G;G;A	230;229;227	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2672	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1915	173.4	0	.	p	.	0	.	INDELS	629	630	AA	1075	1077	TAG	232;233;235	T;A,G;G	232;232,1;235	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2672	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1915	173.4	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1079	1082	CAAT	235;235;236;239	C;A,C;A;T,G	235;234,1;236;238,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2672	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1915	173.4	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1084	1084	T	241	T,C	240,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2672	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1915	173.4	1	SNP	p	G120K	0	.	.	358	360	GGT	803	805	GGT	239;241;242	G;G,C;T	239;240,1;242	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2672	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1915	173.4	1	SNP	p	A121D	0	.	.	361	363	GCC	806	808	GCC	237;238;239	G;C;C	237;238;239	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2672	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1915	173.4	1	SNP	p	A121N	0	.	.	361	363	GCC	806	808	GCC	237;238;239	G;C;C	237;238;239	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9048	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5416	208.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1284	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1440	111.2	1	SNP	p	V57M	1	.	.	169	171	ATG	710	712	ATG	234;235;236	A;T;G	233;235;236	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
